Rapid Read D-Dimer Test Kits for Fluorescence Immunoassay
|FOB Price:||Get Latest Price|
|Min. Order:||1,000 Pieces|
|Production Capacity:||1, 000, 000.00/Month|
|Payment Terms:||L/C, T/T, D/P, Western Union, Paypal, Money Gram|
- Model NO.: NRM-FI-1000
- Type: Test Kits
- Group: All People
- Transport Package: in Carton
- HS Code: 3002100090
- Classification: Biological Diagnostics
- Certification: CE, SGS, ISO13485, RoHS
- Trademark: NORMAN
- Origin: Jiangsu, China
Quick read D-Dimer test kits
1.Negative exclusion indicator of venous thromboembolism.
2.High sensitivity, VTE negative predictive value ≥99%.
3.D-dimer is a product of fibrin clot digestion and therefore is an indicator of recent or
current clot formation and lysis.
4.It is the most frequently used marker of coagulation and fibrinolysis.
Clinical Utility Of The D-dimer Assay
The utility of the assay lies in its negative predictive value since a high D-dimer is a
non-specific finding. A negative result (D-dimer concentration below the cut-off) can
be used to assist in the exclusion of VTE in certain patient populations.
D-dimer testing is often utilized in a diagnostic algorithm which combines clinical decision
rules and imaging studies. If the clinical decision rule categorizes a patient as low or unlikely
to have VTE and the patient has a negative D-dimer test (using a sensitive assay), then the
diagnosis is excluded.
1.Deep vein thrombosis (DVI) and exclusion diagnosis of pulmonary embolism(PE).
2.Diagnosis of disseminated intravascular coagulation(DIC).
3.Effective detection and evaluation indicator of thrombolytic effect.
4.Condition evaluation of cardiovascular disease.
5.Identification and treatment detection of cerebral infarction.
ICU, outpatient emergency, surgery, respiration, cardiology, internal medicine-
neurology, geriatric, oncology, gynecology.
2.Convenient use: test card is aluminum foil bag for 1 person per bag, test immediately
when patient comes.
3.Small sample size: 30ul (plasma).
4.High accuracy: 99% correlation with Siemens D-Dimer.
5.Wide linear range:0.1-10mg/l.
Correlation analysis between Norman D-Dimer and Siemens D-Dimer
European society of Cardiology
Guidelines for the diagnosis and treatment of acute pulmonary embolism.
Recommend to use D-Dimer test as the screening indicator of pulmonary embolism
diagnosis in emergency department.
Clinical and laboratory standards institute.
H59-P guideline: In low and middle clinical risk peak, D-Dimer quantitative test is used
for exclusion diagnosis of venous thrombus embolism(VET).
Package & Delivery
Related test kits
PCT(whole blood), PCT (surum), hs-CRP
NAGL, RBP,Cys-c, mAlb, B2-MG
PG I / PG II / PGR/ HP/ FOB
Nanjing Norman Biological Technology Co., Ltd is dedicated to R&D and manufacturing
of automated chemiluminescence system. Founded in 2008, Norman biological has been
upholding the idea that R&D shapes future ,and concentration determines success. Ever
since the beginning, Norman has been focusing on developing and manufacturing
chemiluminescence instruments and reagents.
Norman's manufacture center is located in the Yuhua District and owns an over 2,000m2
GMP-approved clean workshop. The R&D base, which is over 2,000m2 , is located in state-
level new Jiangbei district. Now there are over 100 R&D engineers, 40% of which hold a
PhD or master's degree.
Powered by advanced technology and excellent talents in the IVD field, Norman has been
consistently improving its innovation platform , and increasing R&D investment. Self-
innovation, combined with long-term strategic cooperation with universities and research
institutes and with outsourced technologies, ensures consistent improvement on product
quality. Norman's R&D field has covered instruments, reagents, and raw materials, and
has been entrusted by the Nanjing government to build a R&D center specialized in biological chemistry and immunity diagnosis. Up to now, Norman has acquired over 20 patents.
Being an expert in automated chemiluminescence analysis , Norman owns independent
and completed intellectual property rights, and its products provide top-notch sensitivity,
precision and accuracy . Thanks to the self-developed antigens and self-manufactured
antibodies, Norman's products features minimized intra-and inter-batch difference.
After 8 years development, Norman is now on the fast track. An over 30,000m2 global
R&D center is in construction, and will hold more than 1,000 R&D engineers in the future.
R&D shapes future, and concentration determines success. Driven by the commitment to
"provide complete solution to improve human health", Norman will consistently do its
utmost to drive the IVD industry forward and contribute more to human health.
If you are interested in working with us, please feel free to contact.